Enzyme Engineering Enabling Scalable Industrial Biotransformation for Sustainable API Production

In 2023, an era of advanced enzyme engineering technology is rapidly enabling the generation of game-changing enzymes for novel transformations. As witnessed for Merck’s Islatravir and BMS’ ERED/KRED biocatalytic cascade recognition, industries are fast transitioning towards biocatalysis to capitalize on more sustainable means of synthesis. The 3^rd Applied Biocatalysis Summit is your must-attend meeting dedicated to accelerating enzyme discovery and reaction route development, through to scaling process chemistry for industrial applications.

With unmissable case studies from the likes of Merck, Amgen, Sanofi, Biogen, GSK, and Pfizer, this is the definitive forum to benchmark and learn with this forward-thinking community who reunite once more.

These industry titans have collaborated to form a comprehensive, 3-day program covering key topics including:

• Gaining valuable insights on chemoenzymatic catalysis research, combining heterogeneous and homogeneous catalysis and making valued functionality using biocatalysis, in water with Bruce Lipshutz, Professor of Chemistry, University of California, Santa Barbara
• Learn how new technologies are adding efficiencies to biocatalysis’ adoption, including AI/ML approaches, improved screening for reaction prediction & new chemistry discoveries with Merck & Pfizer
• Engage in dynamic panel discussions addressing how cross-departmental collaboration enable the faster assessment and introduction of enzymatic catalysed reactions as early as possible with AbbVie, Biogen & Neorocrine Biosciences

Don’t miss this opportunity to join trailblazers and accelerate enzyme discovery and engineering, discover carbon footprint-reducing reactions and refine your process scaling strategies.